Mahinay, Rolyniza .

HRN: 19-20-92  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/31/2026
CO-AMOXICLAV 625MG (TAB)
03/31/2026
04/07/2026
ORAL
625mg
BID
UTI
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines